Cargando…
A pre-therapeutic coating for medical devices that prevents the attachment of Candida albicans
BACKGROUND: Hospital acquired fungal infections are defined as “never events”—medical errors that should never have happened. Systemic Candida albicans infections results in 30–50% mortality rates. Typically, adhesion to abiotic medical devices and implants initiates such infections. Efficient adhes...
Autores principales: | Vargas-Blanco, Diego, Lynn, Aung, Rosch, Jonah, Noreldin, Rony, Salerni, Anthony, Lambert, Christopher, Rao, Reeta P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438570/ https://www.ncbi.nlm.nih.gov/pubmed/28526091 http://dx.doi.org/10.1186/s12941-017-0215-z |
Ejemplares similares
-
Probiotic Yeasts Inhibit Virulence of Non-albicans Candida Species
por: Kunyeit, Lohith, et al.
Publicado: (2019) -
Secondary Metabolites from Food-Derived Yeasts Inhibit Virulence of Candida albicans
por: Kunyeit, Lohith, et al.
Publicado: (2021) -
The evolution of drug resistance in clinical isolates of Candida
albicans
por: Ford, Christopher B, et al.
Publicado: (2015) -
Candida albicans biofilm development is governed by cooperative attachment and adhesion maintenance proteins
por: McCall, Andrew D., et al.
Publicado: (2019) -
Erratum for Kunyeit et al., “Secondary Metabolites from Food-Derived Yeasts Inhibit Virulence of Candida albicans”
por: Kunyeit, Lohith, et al.
Publicado: (2021)